HIV co-testing among veterans with chronic hepatitis C in the veterans health administration

Open Infectious Diseases Journal

Volumn 5, Issue 1, 2011, Pages 91-96

  Fuller, Bret E ^a,b   Rodriguez, Veronica L ^a   Linke, Alex ^a   Hauser, Peter ^c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VISN 22 Network Office   (United States)

Author keywords

Co testing; Hepatitis C; HIV; Testing; Veterans

Indexed keywords

ALPHA INTERFERON;

ADULT; CANNABIS ADDICTION; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE REGISTRY; DISEASE SEVERITY; DRUG DEPENDENCE; FACTORIAL ANALYSIS; FEMALE; HCV TEST; HEALTH CARE MANAGEMENT; HEPATITIS C; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; REVIEW; SUBSTANCE ABUSE; VETERAN;

CANNABIS SATIVA; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80053517782     PISSN: None     EISSN: 18742793     Source Type: Journal    
DOI: 10.2174/1874279301105010091     Document Type: Review

References (25)

1. National Institutes of Health Consensus Development Conference Statement Management of hepatitis C 2002.
2. Bräu N, Bini E, Shahidi A, et al. Prevalence of hepatitis c and coinfection with HIV among United States veterans in the New York metropolitan area. Am J Gastroenterol 2002; 97: 2071-8.
3. Dominitz J, Boyko E, Koepsell T, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41: 88-96.
4. Philips B, Mole L, Backus L, et al. Caring for veterans with HIV disease. Washington DC, Department of Veterans Affairs 2003.
5. Valdiserri R, Rodriguez F, Holodniy, M. Frequency of HIV screening in the Veterans Health Administration: implications for early diagnosis of HIV infection. AIDS Educ Prev 2008; 20: 258-64.
6. Backus L, Boothroyd B, Deyton LR. HIV, hepatitis C and HIV/hepatitis C co-infection in vulnerable populations. AIDS 2005; 19: 513-9.
7. Bini E, Currie S, Shen H, et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gasteroenterol 2006; 40: 732-9.
8. Andersson K, Chung R. Hepatitis C virus in the HIV-infected patient. Clin Liver Dis 2006; 10: 303-20.
9. Rosenburg S, Goodman L, Osher F. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91: 31-7.
10. Rosenberg S, Drake R, Brunette, M, et al. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS 2005; 19: S26-S33.
11. Rockstroch JK, Spengler U. HIV and hepatitis c virus co-infection. Lancet 2004; 4: 437-44.
12. Graham CS, Banden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis 2001; 33: 562-9.
13. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing. JAIDS 2007; 46: S3-S8.
14. Rothman RE, Ketlogetswe KS, Dolan T, Wyer PC, Kelen GD. Preventive Care in the Emergency Department: Should Emergency Departments conduct routine HIV screening? A systematic review. Acad Emer Med 2003; 10: 278-85.
15. Branson B Current HIV Epidemiology and Revised Recommendations for HIV Testing in Health-Care Settings. J Med Vir 2007; 79: S6-S10.
16. Huckans MS, Blackwell AD, Harms TA, Indest DW, Hauser P. Integrated hepatitis C virus treatment: Addressing cormorbid substance use disorders and HIV infection. AIDS 2005; 19: S106-S115.
17. Wright TL, Yee H. VA treatment recommendations (version 5.0). In: Federal Practitioner, Edited by Veterans Health Administration 2003; 20(S5): 1-33.
18. Centers for Disease Control. Revised guidelines for HIV counseling, testing, and referral. MMWR 2001; 50 (No. RR-19): 1-62.
19. Centers for Disease Control (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. Recommendations and Reports. September 22, 2006/55 (RR14); 1-17. http://www.cdc.gov/mmwr/preview/mmwr html/rr5514a1.htm
20. Borghi V, Puoti M, Mussini C, et al. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. Antivir Ther. 2008; 13(8): 1057-65.
21. Loftis JM, Hauser P. Treating Hepatitis C in Patients with Comorbid Psychiatric and Substance Use Disorders. Dir Psych 2008; 28(4): 227-243
22. Goetz MB, Bowman C, Hoang T, et al. Implementing and evaluating a regional strategy to improve testing rates in VA patients at risk for HIV, utilizing the QUERI process as a guiding framework: QUERI Series. Implement Sci 2008: 3-16
23. Gandhi NR, Skanderson M, Gordon KS. Concato J, Justice AC. Delayed presentation for human immunodeficiency virus (HIV) care among Veterans. Med Care 2007; 45: 1105-9.
24. Rifai MA, Moles JK, Lehman LP, Van Der Linde BJ. Hepatitis C screening and treatment outcomes in patients with substance use/dependent disorders. Psychosom 2006; 47: 112-21.
25. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance abuse disorders: Concepts and approaches. AIDS 2005; S3; s227-s237.